Aspen Aerogels (NYSE:ASPN - Get Free Report) issued an update on its second quarter 2025 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of -0.130--0.05 for the period, compared to the consensus estimate of 0.010. The company issued revenue guidance of $70.0 million-$80.0 million, compared to the consensus revenue estimate of $90.9 million.
Analyst Ratings Changes
A number of research firms recently commented on ASPN. StockNews.com raised shares of Aspen Aerogels to a "sell" rating in a research note on Wednesday, February 19th. Roth Mkm lowered their price objective on Aspen Aerogels from $22.00 to $16.00 and set a "buy" rating on the stock in a report on Friday, February 14th. Oppenheimer cut Aspen Aerogels from an "outperform" rating to a "market perform" rating in a research report on Thursday. Seaport Res Ptn downgraded shares of Aspen Aerogels from a "strong-buy" rating to a "hold" rating in a report on Wednesday, February 12th. Finally, Barclays lowered their price target on shares of Aspen Aerogels from $25.00 to $13.00 and set an "overweight" rating on the stock in a report on Wednesday, February 19th. One analyst has rated the stock with a sell rating, two have given a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, Aspen Aerogels presently has a consensus rating of "Moderate Buy" and an average target price of $19.11.
Read Our Latest Stock Analysis on ASPN
Aspen Aerogels Trading Up 14.8 %
Shares of NYSE:ASPN traded up $0.64 during midday trading on Friday, hitting $4.95. 3,835,747 shares of the stock were exchanged, compared to its average volume of 1,934,134. Aspen Aerogels has a 12 month low of $4.16 and a 12 month high of $33.15. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.48 and a current ratio of 2.93. The stock has a market capitalization of $406.42 million, a price-to-earnings ratio of 30.94 and a beta of 2.72. The business's 50-day moving average price is $6.08 and its 200 day moving average price is $10.53.
Aspen Aerogels (NYSE:ASPN - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The construction company reported ($0.06) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.07) by $0.01. The company had revenue of $78.72 million for the quarter, compared to the consensus estimate of $82.75 million. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%. The firm's revenue was down 16.7% compared to the same quarter last year. During the same period in the previous year, the business earned ($0.02) EPS. Analysts predict that Aspen Aerogels will post 0.17 earnings per share for the current year.
About Aspen Aerogels
(
Get Free Report)
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
Featured Stories

Before you consider Aspen Aerogels, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Aerogels wasn't on the list.
While Aspen Aerogels currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.